About this Journal Submit a Manuscript Table of Contents
Journal of Biomedicine and Biotechnology
Volume 2006 (2006), Article ID 19365, 4 pages
http://dx.doi.org/10.1155/JBB/2006/19365
Mini-Review Article

Mechanisms of Neuronal Death in Synucleinopathy

1Department of Neurology, Center for Asian Traditional Medicine Research, Graduate School of Medicine, Tohoku University, 1-1 Seiryomachi, AobakuSendai 980-8574, Japan
2Department of Geriatric and Complementary Medicine, Center for Asian Traditional Medicine Research, Graduate School of Medicine, Tohoku University, 1-1 Seiryomachi, Aobaku 980-8574, Sendai, Japan

Received 1 December 2005; Accepted 20 March 2006

Copyright © 2006 Atsushi Takeda et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. J L Eriksen, T M Dawson, D W Dickson, and L Petrucelli, “Caught in the act: α-synuclein is the culprit in Parkinson's disease,” Neuron, vol. 40, no. 3, pp. 453–456, 2003. View at Publisher · View at Google Scholar
  2. K K Dev, K Hofele, S Barbieri, V L Buchman, and H Van der Putten, “Part II: α-synuclein and its molecular pathophysiological role in neurodegenerative disease,” Neuropharmacology, vol. 45, no. 1, pp. 14–44, 2003. View at Publisher · View at Google Scholar
  3. S Chandra, G Gallardo, R Fernandez-Chacon, O M Schluter, and T C Sudhof, “α-synuclein cooperates with CSPα in preventing neurodegeneration,” Cell, vol. 123, no. 3, pp. 383–396, 2005. View at Publisher · View at Google Scholar · View at PubMed
  4. E Munoz, R Oliva, V Obach, et al., “Identification of Spanish familial Parkinson's disease and screening for the Ala53Thr mutation of the α-synuclein gene in early onset patients,” Neuroscience Letters, vol. 235, no. 1-2, pp. 57–60, 1997. View at Publisher · View at Google Scholar · View at PubMed
  5. R Kruger, W Kuhn, T Muller, et al., “Ala30Pro mutation in the gene encoding α-synuclein in Parkinson's disease,” Nature Genetics, vol. 18, no. 2, pp. 106–108, 1998. View at Publisher · View at Google Scholar · View at PubMed
  6. J J Zarranz, J Alegre, J C Gomez-Esteban, et al., “The new mutation, E46K, of α-synuclein causes Parkinson and Lewy body dementia,” Annals of Neurology, vol. 55, no. 2, pp. 164–173, 2004. View at Publisher · View at Google Scholar · View at PubMed
  7. M B Feany and W W Bender, “A Drosophila model of Parkinson's disease,” Nature, vol. 404, no. 6776, pp. 394–398, 2000. View at Publisher · View at Google Scholar · View at PubMed
  8. J L Eriksen, Z Wszolek, and L Petrucelli, “Molecular pathogenesis of Parkinson disease,” Archives of Neurology, vol. 62, no. 3, pp. 353–357, 2005. View at Publisher · View at Google Scholar · View at PubMed
  9. M Matsuzaki, T Hasegawa, A Takeda, et al., “Histochemical features of stress-induced aggregates in α-synuclein overexpressing cells,” Brain Research, vol. 1004, no. 1-2, pp. 83–90, 2004. View at Publisher · View at Google Scholar · View at PubMed
  10. T Hasegawa, M Matsuzaki, A Takeda, et al., “Accelerated α-synuclein aggregation after differentiation of SH-SY5Y neuroblastoma cells,” Brain Research, vol. 1013, no. 1, pp. 51–59, 2004. View at Publisher · View at Google Scholar · View at PubMed
  11. B I Giasson, J E Duda, I V Murray, et al., “Oxidative damage linked to neurodegeneration by selective α-synuclein nitration in synucleinopathy lesions,” Science, vol. 290, no. 5493, pp. 985–989, 2000. View at Publisher · View at Google Scholar · View at PubMed
  12. S R Paik, H J Shin, and J H Lee, “Metal-catalyzed oxidation of α-synuclein in the presence of Copper(II) and hydrogen peroxide,” Archives of Biochemistry and Biophysics, vol. 378, no. 2, pp. 269–277, 2000. View at Publisher · View at Google Scholar · View at PubMed
  13. E Paxinou, Q Chen, M Weisse, et al., “Induction of α-synuclein aggregation by intracellular nitrative insult,” The Journal of Neuroscience, vol. 21, no. 20, pp. 8053–8061, 2001. View at PubMed
  14. V N Uversky, J Li, and A L Fink, “Evidence for a partially folded intermediate in α-synuclein fibril formation,” The Journal of Biological Chemistry, vol. 276, no. 14, pp. 10737–10744, 2001. View at Publisher · View at Google Scholar · View at PubMed
  15. A Kikuchi, A Takeda, and H Onodera, “Systemic increase of oxidative nucleic acid damage in Parkinson's disease and multiple system atrophy,” Neurobiology of Disease, vol. 9, no. 2, pp. 244–248, 2002. View at Publisher · View at Google Scholar · View at PubMed
  16. J A Johnston, C L Ward, and R R Kopito, “Aggresomes: a cellular response to misfolded proteins,” The Journal of Cell Biology, vol. 143, no. 7, pp. 1883–1898, 1998. View at Publisher · View at Google Scholar · View at PubMed
  17. M Tanaka, Y M Kim, G Lee, E Junn, T Iwatsubo, and M M Mouradian, “Aggresomes formed by α-synuclein and synphilin-1 are cytoprotective,” The Journal of Biological Chemistry, vol. 279, no. 6, pp. 4625–4631, 2004. View at Publisher · View at Google Scholar · View at PubMed
  18. M Arrasate, S Mitra, E S Schweitzer, M R Segal, and S Finkbeiner, “Inclusion body formation reduces levels of mutant huntingtin and the risk of neuronal death,” Nature, vol. 431, no. 7010, pp. 805–810, 2004. View at Publisher · View at Google Scholar
  19. M Matsuzaki-Kobayashi, T Hasegawa, A Kikuchi, A Takeda, and Y Itoyama, “Role of iron in the intracellular aggregation of α-synuclein,” Movement Disorders, vol. 19, no. sup9, p. S36, 2004. View at Publisher · View at Google Scholar
  20. H G Lee, R B Petersen, X Zhu, et al., “Will preventing protein aggregates live up to its promise as prophylaxis against neurodegenerative diseases?,” Brain Pathology, vol. 13, no. 4, pp. 630–638, 2003.
  21. S Ueda, S Sakakibara, E Watanabe, K Yoshimoto, and N Koibuchi, “Vulnerability of monoaminergic neurons in the brainstem of the zitter rat in oxidative stress,” Progress in Brain Research, vol. 136, pp. 293–302, 2002.
  22. A H Stokes, T G Hastings, and K E Vrana, “Cytotoxic and genotoxic potential of dopamine,” Journal of Neuroscience Research, vol. 55, no. 6, pp. 659–665, 1999. View at Publisher · View at Google Scholar
  23. J L Bolton, M A Trush, T M Penning, G Dryhurst, and T J Monks, “Role of quinones in toxicology,” Chemical Research in Toxicology, vol. 13, no. 3, pp. 135–160, 2000. View at Publisher · View at Google Scholar
  24. R G Perez, J C Waymire, E Lin, J J Liu, F Guo, and M J Zigmond, “A role for α-synuclein in the regulation of dopamine biosynthesis,” The Journal of Neuroscience, vol. 22, no. 8, pp. 3090–3099, 2002.
  25. F J Lee, F Liu, Z B Pristupa, and H B Niznik, “Direct binding and functional coupling of α-synuclein to the dopamine transporters accelerate dopamine-induced apoptosis,” FASEB Journal, vol. 15, no. 6, pp. 916–926, 2001. View at Publisher · View at Google Scholar
  26. R G Perez and T G Hastings, “Could a loss of α-synuclein function put dopaminergic neurons at risk?,” Journal of Neurochemistry, vol. 89, no. 6, pp. 1318–1324, 2004. View at Publisher · View at Google Scholar · View at PubMed
  27. A Sidhu, C Wersinger, and P Vernier, “α-synuclein regulation of the dopaminergic transporter: a possible role in the pathogenesis of Parkinson's disease,” FEBS Letters, vol. 565, no. 1–3, pp. 1–5, 2004. View at Publisher · View at Google Scholar
  28. K A Conway, J C Rochet, R M Bieganski, and P T Jr Lansbury, “Kinetic stabilization of the α-synuclein protofibril by a dopamine-α-synuclein adduct,” Science, vol. 294, no. 5545, pp. 1346–1349, 2001. View at Publisher · View at Google Scholar
  29. H T Li, D H Lin, X Y Luo, et al., “Inhibition of α-synuclein fibrillization by dopamine analogs via reaction with the amino groups of α-synuclein: implication for dopaminergic neurodegeneration,” FEBS Journal, vol. 272, no. 14, pp. 3661–3672, 2005. View at Publisher · View at Google Scholar
  30. A Takeda, Y Tomita, S Okinaga, H Tagami, and S Shibahara, “Functional analysis of the cDNA encoding human tyrosinase precursor,” Biochemical and Biophysical Research Communications, vol. 162, no. 3, pp. 984–990, 1989. View at Publisher · View at Google Scholar
  31. T Hasegawa, M Matsuzaki, A Takeda, et al., “Increased dopamine and its metabolites in SH-SY5Y neuroblastoma cells that express tyrosinase,” Journal of Neurochemistry, vol. 87, no. 2, pp. 470–475, 2003. View at Publisher · View at Google Scholar
  32. T Hasegawa, M Matsuzaki-Kobayashi, A Takeda, et al., “Synergistic interaction between α-synuclein and oxidized catechol metabolites produced by tyrosinase: implications for selective neurodegeneration in Parkinson's disease,” FEBS Letters, vol. 580, pp. 2147–2152, 2006. View at Publisher · View at Google Scholar
  33. H A Lashuel, D Hartley, B M Petre, T Walz, and P T Jr Lansbury, “Neurodegenerative disease: amyloid pores from pathogenic mutations,” Nature, vol. 418, no. 6895, p. 291, 2002. View at Publisher · View at Google Scholar
  34. M J Volles and P T Jr Lansbury, “Vesicle permeabilization by protofibrillar α-synuclein is sensitive to Parkinson's disease-linked mutations and occurs by a pore-like mechanism,” Biochemistry, vol. 41, no. 14, pp. 4595–4602, 2002. View at Publisher · View at Google Scholar
  35. R Kayed, Y Sokolov, B Edmonds, et al., “Permeabilization of lipid bilayers is a common conformation-dependent activity of soluble amyloid oligomers in protein misfolding diseases,” The Journal of Biological Chemistry, vol. 279, no. 45, pp. 46363–46366, 2004. View at Publisher · View at Google Scholar
  36. M R Gluck and G D Zeevalk, “Inhibition of brain mitochondrial respiration by dopamine and its metabolites: implications for Parkinson's disease and catecholamine-associated diseases,” Journal of Neurochemistry, vol. 91, no. 4, pp. 788–795, 2004. View at Publisher · View at Google Scholar
  37. K Furukawa, M Matsuzaki-Kobayashi, T Hasegawa, et al., “High ion permeability of plasma membrane caused by the α-synuclein mutations contributes to cellular degeneration,” Journal of Neurochemistry, vol. 97, pp. 1071–1077, 2006. View at Publisher · View at Google Scholar
  38. M P Mattson and S L Chan, “Dysregulation of cellular calcium homeostasis in Alzheimer's disease: bad genes and bad habits,” Journal of Molecular Neuroscience, vol. 17, no. 2, pp. 205–224, 2001. View at Publisher · View at Google Scholar
  39. K Furukawa, Y Wang, P J Yao, et al., “Alteration in calcium channel properties is responsible for the neurotoxic action of a familial frontotemporal dementia tau mutation,” Journal of Neurochemistry, vol. 87, no. 2, pp. 427–436, 2003. View at Publisher · View at Google Scholar